Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

Clinical trial NCT01323959 · COMPLETED

Trial details

NCT number: NCT01323959
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acellular Pertussis Poliomyelitis Diphtheria Tetanus

Start date: 2011-04-01
Primary completion: 2012-03-01
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.